OzmoCAP®

OzmoCAP®
Product Description

OzmoCAP® capsules themselves control drug release for any drug allowing the OzmoCAP® team to very quickly develop and deliver the drug product with predetermined controlled release behavior to an animal laboratory for Proof-of-Concept studies.




OzmoCAP® allows rapid development of oral extended-release drug products.




OzmoCAP® provides known in vivo drug delivery rates set by the OzmoCAP® formulation independent of the drug's properties.




OzmoCAP® delivers the drug with options for release rates, all with good in vitro-in vivo correlation (IVIVC): fast, medium, and slow.

FreeThink Technologies, Inc.

  • Country/Region:
    United States
  • On CPHI since:
    2018
  • Certificates:
    2
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
CMO/CDMO
Consumer Goods
Drug delivery device Supplier/Manufacturer
Innovation cluster
OTC
Pharmaceutical company
Veterinary Company
Primary activities
Contract Research Organisation
Laboratory Services
Nutraceuticals
OTC
Technology

FreeThink Technologies, Inc.

  • Country/Region:
    United States
  • On CPHI since:
    2018
  • Certificates:
    2
  • Employees:
    25 - 49
Company types
Biopharmaceutical company
CMO/CDMO
Consumer Goods
Drug delivery device Supplier/Manufacturer
Innovation cluster
OTC
Pharmaceutical company
Veterinary Company
Primary activities
Contract Research Organisation
Laboratory Services
Nutraceuticals
OTC
Technology

More Products from FreeThink Technologies, Inc. (1)

  • Accelerated Stability Assessment Program (ASAP) and Laboratory Services

    Product Accelerated Stability Assessment Program (ASAP) and Laboratory Services

    FreeThink is a global leader in the science and technology of stability.  In addition to lab services, FreeThink licenses ASAPprime®, a proprietary software which we developed based on the Accelerate Stability Assessment Program (ASAP) to determine shelf-life.  ASAP can speed and streamline p...

FreeThink Technologies, Inc. resources (1)